CatalystFDA/Bio

$ARWR

- ARROWHEAD'S PLOZASIRAN REDUCES ACUTE PANCREATITIS EVENTS IN SEVERE HYPERTRIGLYCERIDEMIA

ARWR

$84.91

-4.15%

What changed

- ARROWHEAD'S PLOZASIRAN REDUCES ACUTE PANCREATITIS EVENTS IN SEVERE HYPERTRIGLYCERIDEMIA

Why it matters

Phase 3 data shows plozasiran cut acute pancreatitis events in severe hypertriglyceridemia.

Sources